Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPAGLIFLOZIN PROPANEDIOL for Hyperglycaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where DAPAGLIFLOZIN PROPANEDIOL was used for Hyperglycaemia.

Most Reported Side Effects for DAPAGLIFLOZIN PROPANEDIOL

Side Effect Reports % Deaths Hosp.
Death 3,443 20.4% 3,439 35
Fungal infection 1,204 7.1% 4 63
Blood glucose increased 778 4.6% 7 103
Weight decreased 777 4.6% 11 70
Urinary tract infection 583 3.5% 9 186
Dizziness 582 3.5% 8 71
Diabetic ketoacidosis 547 3.2% 5 384
Nausea 460 2.7% 9 98
Fatigue 442 2.6% 4 50
Pollakiuria 388 2.3% 1 20
Cerebrovascular accident 352 2.1% 14 73
Drug ineffective 352 2.1% 6 22
Diarrhoea 350 2.1% 2 53
Dehydration 342 2.0% 7 133
Dyspnoea 331 2.0% 11 83

Other Indications for DAPAGLIFLOZIN PROPANEDIOL

Type 2 diabetes mellitus (3,053) Diabetes mellitus (1,611) Product used for unknown indication (776) Cardiac failure (406) Chronic kidney disease (374) Renal disorder (124) Weight decreased (97) Cardiac disorder (83) Blood glucose abnormal (67) Glycosylated haemoglobin increased (65)

Other Drugs Used for Hyperglycaemia

METFORMIN (373) INSULIN GLARGINE (198) INSULIN NOS (87) INSULIN HUMAN (85) DAPAGLIFLOZIN (70) INSULIN ASPART (69) EMPAGLIFLOZIN (67) INSULIN LISPRO (61) MIFEPRISTONE (52) GLIMEPIRIDE (43)

Related Pages

DAPAGLIFLOZIN PROPANEDIOL Full Profile All Hyperglycaemia Drugs DAPAGLIFLOZIN PROPANEDIOL Demographics DAPAGLIFLOZIN PROPANEDIOL Timeline